Division of Cardiovascular Medicine, University of Missouri School of Medicine, Columbia.
Division of Cardiovascular Medicine, University of Missouri School of Medicine, Columbia.
Am J Med. 2016 Jul;129(7):753.e7-753.e11. doi: 10.1016/j.amjmed.2016.01.037. Epub 2016 Feb 18.
Diuretic therapy is a cornerstone in the management of heart failure. Most studies assessing body thiamine status have reported variable degrees of thiamine deficiency in patients with heart failure, particularly those treated chronically with high doses of furosemide. Thiamine deficiency in patients with heart failure seems predominantly to be due to increased urine volume and urinary flow rate. There is also evidence that furosemide may directly inhibit thiamine uptake at the cellular level. Limited data suggest that thiamine supplementation is capable of increasing left ventricular ejection fraction and improving functional capacity in patients with heart failure and a reduced left ventricular ejection fraction who were treated with diuretics (predominantly furosemide). Therefore, it may be reasonable to provide such patients with thiamine supplementation during heart failure exacerbations.
利尿疗法是心力衰竭管理的基石。大多数评估机体硫胺素状况的研究报告称,心力衰竭患者存在不同程度的硫胺素缺乏,尤其是长期接受大剂量呋塞米治疗的患者。心力衰竭患者的硫胺素缺乏主要归因于尿量和尿流率增加。还有证据表明,呋塞米可能直接在细胞水平上抑制硫胺素摄取。有限的数据表明,硫胺素补充剂能够增加心力衰竭和左心室射血分数降低且接受利尿剂(主要是呋塞米)治疗患者的左心室射血分数,并改善其心功能。因此,在心力衰竭加重期间为这些患者提供硫胺素补充可能是合理的。